Clinical Trial Update: INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intranasal oxytocin for Autism Spectrum Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: Holland Bloorview Kids Rehabilitation Hospital | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED